Fatty liver disease is not just a liver problem: how gut microbes, genes and metabolism collide
A new review explains how gut microbes, host genetics and metabolic dysfunction interact to drive MASLD and shape emerging therapies.
A new review explains how gut microbes, host genetics and metabolic dysfunction interact to drive MASLD and shape emerging therapies.
Scientists engineered a probiotic bacterium that produces the anti-inflammatory lipid palmitoylethanolamide directly in the gut, protecting mice with chronic colitis ...
Metabolic dysfunction-associated steatotic liver disease, known as MASLD, has quietly become the most common chronic liver condition on the planet, ...
A new review maps how gut bacteria, their metabolites, and liver-resident cells collaborate to build a pre-metastatic niche that primes ...
A bidirectional Mendelian randomization study shows that genetic liability to primary biliary cirrhosis causally raises the risk of ulcerative colitis, ...
A new review finds that saikosaponins from Radix Bupleuri and acupuncture show partially overlapping liver-protective mechanisms, but stresses that combining ...
A new review proposes that lipid metabolism plays fundamentally different roles at each stage of fatty liver disease progression to ...
A new review maps how gut microbes and their metabolites bidirectionally shape T cell immunity to drive autoimmune, alcohol-associated, metabolic ...
A metagenomic study of Han and Uyghur men reveals that alcohol use disorder depletes the same beneficial short-chain fatty acid-producing ...
Researchers report that Klebsiella pneumoniae enriched in the guts of primary biliary cholangitis patients can translocate to the liver and ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine